Chetasi Talati, MD

Articles by Chetasi Talati, MD

Dr. Talati on Rationale for Collecting Real-World Data on Venetoclax/HMA Combos in AML

July 8th 2020

Chetasi Talati, MD, discusses the design of a chart review study with venetoclax and hypomethylating agents in older patients with newly-diagnosed acute myeloid leukemia.

Dr. Talati on the Rationale for Venetoclax in AML

ByChetasi Talati, MD

June 19th 2020

Chetasi Talati, MD, discusses the rationale for investigating venetoclax in acute myeloid leukemia.

Dr. Talati on Real-World Data With Venetoclax Combinations in AML

ByChetasi Talati, MD

June 13th 2020

Chetasi Talati, MD, discusses the ongoing safety analysis of venetoclax (Venclexta)-based combinations in patients with newly diagnosed acute myeloid leukemia.